{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:11:38Z","timestamp":1788869498860,"version":"build-2803163510"},"reference-count":98,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T00:00:00Z","timestamp":1423180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CNPq\/Brazil"},{"name":"PRPq\/UFMG"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Brasileira de Hematologia e Hemoterapia"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.bjhh.2015.02.001","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T01:27:36Z","timestamp":1424136456000},"page":"190-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Resistance of dialyzed patients to erythropoietin"],"prefix":"10.1016","volume":"37","author":[{"given":"Michelle Teodoro","family":"Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Simone","family":"Vila\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria das Gra\u00e7as","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luci Maria Sant\u2019Ana","family":"Dusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Braga","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjhh.2015.02.001_bib0495","first-page":"183","article-title":"A doen\u00e7a renal cr\u00f4nica: do diagn\u00f3stico ao tratamento","volume":"52","author":"Rom\u00e3o Junior","year":"2007","journal-title":"Pr\u00e1tica Hospitalar"},{"key":"10.1016\/j.bjhh.2015.02.001_bib0500","unstructured":"Manual de Transplante Renal. Associa\u00e7\u00e3o Brasileira de Transplantes de \u00d3rg\u00e3os (ABTO). Available from: http:\/\/www.abto.org.br\/abtov03\/Upload\/file\/Profissional_Manual\/manual_transplante_rim.pdf [cited 31.10.14]."},{"key":"10.1016\/j.bjhh.2015.02.001_bib0505","unstructured":"Censo da Sociedade Brasileira de Nefrologia 2013. S\u00e3o Paulo: Sociedade Brasileira de Nefrologia (SBN). Available from: http:\/\/www.sbn.org.br\/pdf\/censo_2013-14-05.pdf [cited 31.10.14]."},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.001_bib0510","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1053\/ajkd.2001.27699","article-title":"Anemia: an early complication of chronic renal insufficiency","volume":"38","author":"Kazmi","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.bjhh.2015.02.001_bib0515","first-page":"1","article-title":"K\/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","volume":"26","author":"National Kidney Foundation","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"783","key":"10.1016\/j.bjhh.2015.02.001_bib0520","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/pgmj.67.783.9","article-title":"The use of erythropoietin in renal failure","volume":"67","author":"Macdougall","year":"1991","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.bjhh.2015.02.001_bib0525","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0272-6386(97)90116-5","article-title":"A cost-effectiveness analysis of anemia screening before erythropoietin in patients with endstage renal disease","volume":"29","author":"Hutchinson","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.bjhh.2015.02.001_bib0530","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5935\/0101-2800.20140009","article-title":"Relat\u00f3rio do Censo Brasileiro de Di\u00e1lise 2012","volume":"36","author":"Sesso","year":"2014","journal-title":"J Bras Nefrol"},{"issue":"Suppl. 2","key":"10.1016\/j.bjhh.2015.02.001_bib0535","first-page":"ii1","article-title":"Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.bjhh.2015.02.001_bib0540","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2007.06.008","article-title":"KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target","volume":"50","author":"KDOQI","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.bjhh.2015.02.001_bib0545","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ndt\/gfn653","article-title":"Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP)","volume":"24","author":"Locatelli","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bjhh.2015.02.001_bib0550","first-page":"279","article-title":"KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","author":"KDIGO.","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1016\/j.bjhh.2015.02.001_bib0555","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/gfg458","article-title":"Anaemia in hemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bjhh.2015.02.001_bib0560","series-title":"Anemia em pacientes com insufici\u00eancia renal cr\u00f4nica \u2013 alfaepoetina","author":"Brasil. Minist\u00e9rio da Sa\u00fade Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas","year":"2010"},{"issue":"1 Suppl. 1","key":"10.1016\/j.bjhh.2015.02.001_bib0565","first-page":"9","article-title":"Diagn\u00f3stico de Anemia em Pacientes Portadores de Doen\u00e7a Renal Cr\u00f4nica","volume":"36","author":"Ribeiro-Alves","year":"2014","journal-title":"J Bras Nefrol"},{"issue":"3","key":"10.1016\/j.bjhh.2015.02.001_bib0570","first-page":"26","article-title":"Anemia da doen\u00e7a renal cr\u00f4nica","volume":"26","author":"Abensur","year":"2004","journal-title":"J Bras Nefrol"},{"issue":"10","key":"10.1016\/j.bjhh.2015.02.001_bib0575","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1373\/49.10.1573","article-title":"Iron deficiency and erythropoiesis: new diagnostic approaches","volume":"49","author":"Brugnara","year":"2003","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.bjhh.2015.02.001_bib0580","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0272-6386(97)90104-9","article-title":"Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO","volume":"30","author":"Mittman","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.001_bib0585","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajh.21090","article-title":"Reticulocyte hemoglobin content","volume":"83","author":"Mast","year":"2008","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.bjhh.2015.02.001_bib0590","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1046\/j.1523-1755.2001.00077.x","article-title":"A randomized trial of iron deficiency testing strategies in hemodialysis patients","volume":"60","author":"Fishbane","year":"2001","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.bjhh.2015.02.001_bib0595","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1182\/blood.V83.10.3100.3100","article-title":"Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy","volume":"83","author":"Brugnara","year":"1994","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bjhh.2015.02.001_bib0600","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/clinchem\/48.7.1066","article-title":"Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency","volume":"48","author":"Thomas","year":"2002","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.bjhh.2015.02.001_bib0605","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1159\/000127981","article-title":"The role of anemia management in improving outcomes for African Americans with chronic kidney disease","volume":"28","author":"Lea","year":"2008","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.bjhh.2015.02.001_bib0610","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ajkd.2003.07.016","article-title":"Malnutrition\u2013inflammation complex syndrome in dialysis patients: causes and consequences","volume":"42","author":"Kalantar-zadeh","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.bjhh.2015.02.001_bib0615","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00467-011-1839-4","article-title":"Resistance to erythropoietin-stimulating agents: etiology, evaluation, and therapeutic considerations","volume":"27","author":"Bamgbola","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"Suppl. 1","key":"10.1016\/j.bjhh.2015.02.001_bib0620","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation","author":"Wish","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.bjhh.2015.02.001_bib0625","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood.V80.7.1639.1639","article-title":"Progress in understanding the pathogenesis of the anemia of chronic disease","volume":"80","author":"Means","year":"1992","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bjhh.2015.02.001_bib0630","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bjhh.2015.02.001_bib0635","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood-2005-04-1766","article-title":"Synthetic hepcidin causes rapid dose-dependent hipoferremia and is concentrated in ferroportin-containing organs","volume":"106","author":"Rivera","year":"2005","journal-title":"Blood"},{"issue":"5704","key":"10.1016\/j.bjhh.2015.02.001_bib0640","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.bjhh.2015.02.001_bib0645","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1172\/JCI32701","article-title":"Hepcidin regulation: ironing out the details","volume":"117","author":"De Domenico","year":"2007","journal-title":"J Clin Invest"},{"issue":"2\u20133","key":"10.1016\/j.bjhh.2015.02.001_bib0650","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000243791","article-title":"The role of hepcidin in iron metabolism","volume":"122","author":"Nemeth","year":"2009","journal-title":"Acta Haematol"},{"issue":"9","key":"10.1016\/j.bjhh.2015.02.001_bib0655","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.bjhh.2015.02.001_bib0660","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.bjhh.2015.02.001_bib0665","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1590\/S1516-84842002000200009","article-title":"Anemia de Doen\u00e7a Cr\u00f4nica","volume":"24","author":"Can\u00e7ado","year":"2002","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"S11","key":"10.1016\/j.bjhh.2015.02.001_bib0670","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/17.suppl_11.39","article-title":"Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines","volume":"17","author":"Macdougall","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.001_bib0675","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/515549","article-title":"Iron, infections, and anemia of inflammation","volume":"25","author":"Jurado","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.bjhh.2015.02.001_bib0680","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0609.1991.tb00524.x","article-title":"Immune activation and the anaemia associated with chronic inflammatory disorders","volume":"46","author":"Fuchs","year":"1991","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.bjhh.2015.02.001_bib0685","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ki.2008.301","article-title":"Expansion of cytolytic CD4+CD28\u2212 T cells in end-stage renal disease","volume":"74","author":"Betjes","year":"2008","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.bjhh.2015.02.001_bib0690","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ndt\/18.1.133","article-title":"Poor response to recombinant erythropoietin is associated with loss of T-lymphocyte CD28 expression and altered interleukin-10 production","volume":"18","author":"Cooper","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.bjhh.2015.02.001_bib0695","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1681\/ASN.2009040400","article-title":"CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD","volume":"20","author":"Betjes","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"5130","key":"10.1016\/j.bjhh.2015.02.001_bib0700","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.8211117","article-title":"Erythrocyte P antigen: cellular receptor for B19 parvovirus","volume":"262","author":"Brown","year":"1993","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bjhh.2015.02.001_bib0705","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/rmv.395","article-title":"Parvovirus B19 and the pathogenesis of anaemia","volume":"13","author":"Chisaka","year":"2003","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.bjhh.2015.02.001_bib0710","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1523-1755.2001.059002725.x","article-title":"Relationship between hematocrit and renal function in men and women","volume":"59","author":"Hsu","year":"2001","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.bjhh.2015.02.001_bib0715","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00007890-200101150-00010","article-title":"Nosocomial outbreak of parvovirus b19 infection in a renal transplant unit","volume":"71","author":"Lui","year":"2001","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.bjhh.2015.02.001_bib0720","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5414\/CNP65141","article-title":"A nosocomial parvovirus B19 infection-induced transient aplastic crisis in a patient with chronic renal failure","volume":"65","author":"Ozeki","year":"2006","journal-title":"Clin Nephrol"},{"issue":"6","key":"10.1016\/j.bjhh.2015.02.001_bib0725","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.bjhh.2015.02.001_bib0730","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.transproceed.2005.11.052","article-title":"Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients","volume":"37","author":"Becker","year":"2005","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.001_bib0735","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1159\/000188974","article-title":"Parvovirus B19 and hemodialysis","volume":"72","author":"Guiserix","year":"1996","journal-title":"Nephron"},{"issue":"8","key":"10.1016\/j.bjhh.2015.02.001_bib0740","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1016\/S0041-1345(02)03653-9","article-title":"Parvovirus B19 infection and IGF system components in relation to erythropoiesis in dialyzed patients and kidney transplant recipients","volume":"34","author":"Malyszko","year":"2002","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.bjhh.2015.02.001_bib0745","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/ndt\/13.3.779","article-title":"Parvovirus B19 infection and unresponsiveness to erythropoietin therapy in haemodialysis patients","volume":"13","author":"Duranay","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"28","key":"10.1016\/j.bjhh.2015.02.001_bib0750","article-title":"Human parvovirus B19 infection in a renal transplant recipient: a case report","volume":"6","author":"Alves","year":"2013","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.bjhh.2015.02.001_bib0755","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-6143.2005.01139.x","article-title":"A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature","volume":"6","author":"Egbuna","year":"2006","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.001_bib0760","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0272-6386(01)80114-1","article-title":"Viral infections after renal transplantation","volume":"137","author":"Smith","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.bjhh.2015.02.001_bib0765","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ndt\/14.2.469","article-title":"Concomitant parvovirus B19 and cytomegalovirus infections after living-related renal transplantation","volume":"14","author":"Keung","year":"1999","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.001_bib0770","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1046\/j.1365-2141.2000.02429.x","article-title":"Pure red cell aplasia","volume":"111","author":"Fish","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bjhh.2015.02.001_bib0775","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/sj.ki.5001969","article-title":"Inflammation and wasting in chronic kidney disease: partners in crime","volume":"70","author":"Avesani","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.bjhh.2015.02.001_bib0780","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1523-1755.1998.00812.x","article-title":"Factors predicting malnutrition in hemodialysis patients: a cross-sectional study","volume":"53","author":"Qureshi","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.bjhh.2015.02.001_bib0785","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/ndt\/gfk011","article-title":"Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients","volume":"21","author":"Locatelli","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.bjhh.2015.02.001_bib0790","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.ajkd.2008.12.040","article-title":"Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients","volume":"53","author":"Kalantar-Zadeh","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.001_bib0795","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2215\/CJN.04710709","article-title":"Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic response","volume":"5","author":"Gaweda","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"S5","key":"10.1016\/j.bjhh.2015.02.001_bib0800","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ndt\/17.suppl_5.24","article-title":"Folate metabolism in renal failure","volume":"17","author":"Shaefer","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.bjhh.2015.02.001_bib0805","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1681\/ASN.V8121899","article-title":"Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia","volume":"8","author":"Perna","year":"1997","journal-title":"Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.bjhh.2015.02.001_bib0810","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/089686080002000202","article-title":"Homocysteine, vitamin b12, and serum and erythrocyte folate in peritoneal dialysis and hemodialysis patients","volume":"20","author":"Vecchi","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.bjhh.2015.02.001_bib0815","series-title":"Resistance to recombinant human erythropoietin therapy in haemodialysis patients","article-title":"Special problems in hemodialysis patients Internet","author":"Costa","year":"2011"},{"key":"10.1016\/j.bjhh.2015.02.001_bib0820","first-page":"180","article-title":"Peritoneal dialysis or hemodialysis? A dilemma for the nephrologist","volume":"22","author":"Shahab","year":"2006","journal-title":"Adv Perit Dial"},{"issue":"6 Suppl. 2","key":"10.1016\/j.bjhh.2015.02.001_bib0825","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for nutrition in chronic renal failure","volume":"35","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.bjhh.2015.02.001_bib0830","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/16.1.111","article-title":"Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients","volume":"16","author":"Movilli","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"S5","key":"10.1016\/j.bjhh.2015.02.001_bib0835","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ndt\/17.suppl_5.28","article-title":"Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients","volume":"17","author":"Druek","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl. 1","key":"10.1016\/j.bjhh.2015.02.001_bib0840","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.ASN.0000093369.09194.12","article-title":"Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach","volume":"15","author":"Brancaccio","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"4 Suppl. 3","key":"10.1016\/j.bjhh.2015.02.001_bib0845","first-page":"S1","article-title":"Kidney disease-dialysis outcome quality initiative: K\/DOQI Clinical Practice Guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.bjhh.2015.02.001_bib0850","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM199301213280304","article-title":"Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia","volume":"328","author":"Rao","year":"1993","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bjhh.2015.02.001_bib0855","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2009.12.042","article-title":"The role of the renin\u2013angiotensin system in the regulation of erythropoiesis","volume":"56","author":"Vlahakos","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.001_bib0860","first-page":"157","article-title":"Contribution of the local RAS to hematopoietic function: a novel therapeutic target","volume":"23","author":"Rodgers","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.001_bib0865","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.HYP.16.4.363","article-title":"Angiotensin I converting enzyme and the changes in our concepts through the years","volume":"16","author":"Erd\u00f6s","year":"1990","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.bjhh.2015.02.001_bib0870","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1073\/pnas.86.3.779","article-title":"Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure","volume":"86","author":"Lenfant","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt. 2","key":"10.1016\/j.bjhh.2015.02.001_bib0875","first-page":"373","article-title":"Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl seryl aspartyl lysyl proline","volume":"296","author":"Rieger","year":"1993","journal-title":"Biorem J"},{"issue":"3","key":"10.1016\/j.bjhh.2015.02.001_bib0880","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1172\/JCI118484","article-title":"Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline","volume":"97","author":"Azizi","year":"1991","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.bjhh.2015.02.001_bib0885","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/ajkd.2001.26839","article-title":"Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: relationship with erythropoietin requirements","volume":"38","author":"Meur","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.bjhh.2015.02.001_bib0890","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI10557","article-title":"Lack of angiotensin II \u2013 facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice","volume":"106","author":"Cole","year":"2000","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.bjhh.2015.02.001_bib0895","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.2003.00015.x","article-title":"Maximal suppression of renin\u2013angiotensin system in nonproliferative glomerulonephritis","volume":"63","author":"Iodice","year":"2003","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.001_bib0900","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/01.ASN.0000054495.96193.BF","article-title":"Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy","volume":"14","author":"Jacobsen","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.001_bib0905","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/1568026043451311","article-title":"Hematocrit-lowering effect following inactivation of renin\u2013angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers","volume":"4","author":"Marathias","year":"2004","journal-title":"Curr Top Med Chem"},{"issue":"S5","key":"10.1016\/j.bjhh.2015.02.001_bib0910","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/17.suppl_5.42","article-title":"Antibodies against rHuEPO: native and recombinant","volume":"17","author":"Casadevall","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.bjhh.2015.02.001_bib0915","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/ki.2011.500","article-title":"Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights","volume":"81","author":"Macdougall","year":"2012","journal-title":"Kidney Int"},{"issue":"Suppl. 8","key":"10.1016\/j.bjhh.2015.02.001_bib0920","first-page":"37","article-title":"Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin","volume":"18","author":"Casadevall","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"S4","key":"10.1016\/j.bjhh.2015.02.001_bib0925","doi-asserted-by":"crossref","first-page":"iv16","DOI":"10.1093\/ndt\/gfh1086","article-title":"Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PCRA): an assessment of available procedures","volume":"20","author":"Thorpe","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bjhh.2015.02.001_bib0930","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4076\/1752-1947-3-7335","article-title":"Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report","volume":"3","author":"Behler","year":"2009","journal-title":"J Med Case Rep"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.001_bib0935","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biologicals.2012.02.003","article-title":"Immunogenicity of recombinant human erythropoietin in Korea: a two-year cross-sectional study","volume":"40","author":"Shin","year":"2012","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.bjhh.2015.02.001_bib0940","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1523-1755.2005.00514.x","article-title":"Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients","volume":"68","author":"Kharagjitsingh","year":"2005","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.bjhh.2015.02.001_bib0945","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/ndt\/gfh307","article-title":"High prevalence in Switzerland of pure red-cell aplasia due to anti-erythropoietin antibodies in chronic dialysis patients: report of five cases","volume":"19","author":"Schonholzer","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bjhh.2015.02.001_bib0950","series-title":"Aplasia pura adquirida cr\u00f4nica da s\u00e9rie vermelha","author":"Brasil, Minist\u00e9rio da Sa\u00fade Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas","year":"2010"},{"issue":"S4","key":"10.1016\/j.bjhh.2015.02.001_bib0955","doi-asserted-by":"crossref","first-page":"iv3","DOI":"10.1093\/ndt\/gfh1088","article-title":"What is antibody-mediated pure red cell aplasia (APASV)","volume":"20","author":"Casadevall","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.bjhh.2015.02.001_bib0960","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3858\/emm.2008.40.2.161","article-title":"Polymorphisms in two genes, IL-1 B and ACE, are associated with erythropoietin resistance in Korean patients on maintenance hemodialysis","volume":"40","author":"Jeong","year":"2008","journal-title":"Exp Mol Med"},{"issue":"20","key":"10.1016\/j.bjhh.2015.02.001_bib0965","doi-asserted-by":"crossref","first-page":"14163","DOI":"10.1074\/jbc.274.20.14163","article-title":"Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide","volume":"74","author":"Middleton","year":"1999","journal-title":"J Biol Chem"},{"issue":"933","key":"10.1016\/j.bjhh.2015.02.001_bib0970","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/pmj.79.933.367","article-title":"Recombinant erythropoietin in clinical practice","volume":"79","author":"Ng","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.bjhh.2015.02.001_bib0975","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2369-12-67","article-title":"Association between high-dose erythropoiesis stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors","volume":"12","author":"Inrig","year":"2011","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.bjhh.2015.02.001_bib0980","doi-asserted-by":"crossref","first-page":"e9246","DOI":"10.1371\/journal.pone.0009246","article-title":"Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease","volume":"5","author":"Khankin","year":"2010","journal-title":"PLoS ONE"}],"container-title":["Revista Brasileira de Hematologia e Hemoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516848415000250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516848415000250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T17:48:10Z","timestamp":1651254490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1516848415000250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1516848415000250"],"URL":"https:\/\/doi.org\/10.1016\/j.bjhh.2015.02.001","relation":{},"ISSN":["1516-8484"],"issn-type":[{"value":"1516-8484","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance of dialyzed patients to erythropoietin","name":"articletitle","label":"Article Title"},{"value":"Revista Brasileira de Hematologia e Hemoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjhh.2015.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}